Skip to main content
. 2020 Jan 21;73(2):597–607. doi: 10.3233/JAD-190651

Table 1.

Demographic data

Group N Age MMSE score Male sex, % APOE ɛ4, % Education, y F-U time, months WMC volume, cm3 Vascular burden, %
AD 83 67.2±7.1 23.5±3.5 29 67 10.8±3.5 15.5±17.3 4.3±2.9 13
Mixed 46 71.2±6.0 23.8±3.0 30 67 10.7±3.4 11.5±16.8 9.0±6.1 46
SVD 23 70.3±7.1 25.0±2.3 74 39 11.4±3.3 14.8±17.2 17.0±9.4 78
Controls 126 65.4±7.5 29.4±1.2 38 32 12.2±2.9 10.2±19.8 4.1±6.1 19
MCI-AD 43 66.1±6.4 27.8±1.3 44 72* 11.8±3.5 27.1±12.3 4.3±6.9 22
MCI-Mix 26 70.0±6.3* 26.9±2.2* 31 69* 11.2±4.1 25.7±9.7 8.0±5.3 38
MCI-SVD 16 68.8±7.5 28.3±1.7 56 50 11.9±3.8 38.7±29.9 23.8±7.8* 94*
MCI-MCI 130 65.4±8.1 28.3±1.5 44 38 11.3±3.4 37.8±25.3 5.4±6.6 38

Dementia groups (AD, Mixed, and SVD) were compared with controls. Converting MCI subgroups (MCI-AD, MCI-Mix, and MCI-SVD) were compared with MCI-MCI. APOE ɛ4 %, Percentage of study participant with at least one APOE ɛ4 allele; F-U time, follow up time (time until conversion for converting MCI groups, total follow up time for the other groups); WMC volume, white matter changes volume; Vascular burden, Percentage of study participants with at least two vascular risk factors and not insignificant WMCs. p-value<0.05 versus Controls after Bonferroni correction. *p-value<0.05 versus MCI-MCI after Bonferroni correction.